Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Clinical trial NCT06141486 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06141486
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2028-03-24
- Enrollment
- 943
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.